awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q49307383-164F08F6-2925-438F-903B-16C82115D11A
Q49307383-164F08F6-2925-438F-903B-16C82115D11A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49307383-164F08F6-2925-438F-903B-16C82115D11A
Real-world usage and clinical outcomes of alectinib among post-crizotinib progression anaplastic lymphoma kinase positive non-small-cell lung cancer patients in the USA.
P2860
Q49307383-164F08F6-2925-438F-903B-16C82115D11A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49307383-164F08F6-2925-438F-903B-16C82115D11A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f11ea6048c0aa3c094a3a17439985492c50b6ad7
P2860
Antitumor activity of the selective ALK inhibitor alectinib in models of intracranial metastases.